NCT07825909

Brief Summary

This study evaluated whether immersive virtual reality (VR) could enhance the effects of reminiscence therapy in older adults with cognitive impairment attending day-care services. Participants were assigned to one of three conditions: individual reminiscence therapy supported by immersive VR (RT+VR), individual traditional reminiscence therapy without VR, or usual care. The study examined changes in cognitive functioning, depressive symptoms, neuropsychiatric symptoms, and health-related quality of life. The aim was to determine whether adding an immersive and personalized virtual environment to reminiscence therapy could provide additional benefits compared with traditional reminiscence therapy and usual care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 7, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2024

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 17, 2026

Completed
Last Updated

September 24, 2026

Status Verified

September 1, 2026

Enrollment Period

4 months

First QC Date

September 12, 2026

Last Update Submit

September 21, 2026

Conditions

Keywords

Reminiscence TherapyVirtual RealityOlder AdultsCognitive ImpairmentNon-Pharmacological InterventionHealth-Related Quality of Life

Outcome Measures

Primary Outcomes (4)

  • Change in Global Cognitive Functioning Assessed With the Mini-Mental State Examination (MMSE)

    Global cognitive functioning was assessed using the Mini-Mental State Examination (MMSE). Total scores range from 0 to 30, with higher scores indicating better global cognitive functioning. Total scores were adjusted for age and/or educational level according to the correction procedures used in the study. Change from baseline to post-intervention was compared across the three study groups.

    Baseline and post-intervention, after completion of the 12-session intervention period (approximately 6 weeks).

  • Change in Depressive Symptoms Assessed With the 15-Item Geriatric Depression Scale (GDS-15)

    Depressive symptoms were assessed using the 15-item Geriatric Depression Scale (GDS-15). Total scores range from 0 to 15, with higher scores indicating greater depressive symptom severity and therefore a worse outcome. Change from baseline to post-intervention was compared across the three study groups.

    Baseline and post-intervention, after completion of the 12-session intervention period (approximately 6 weeks)

  • Change in Neuropsychiatric Symptoms Assessed With the Neuropsychiatric Inventory (NPI)

    Neuropsychiatric symptoms were assessed using the Neuropsychiatric Inventory (NPI). For each assessed domain, frequency is multiplied by severity to obtain a domain score ranging from 0 to 12, with higher scores indicating greater neuropsychiatric symptom burden and therefore a worse outcome. Study-derived symptom composite scores were calculated as the mean of the relevant domain scores and therefore also range from 0 to 12, with higher scores indicating greater symptom burden. Change from baseline to post-intervention was compared across the three study groups.

    Baseline and post-intervention, after completion of the 12-session intervention period (approximately 6 weeks)

  • Change in Health-Related Quality of Life Assessed With the 36-Item Short Form Health Survey (SF-36)

    Health-related quality of life was assessed using the 36-Item Short Form Health Survey (SF-36). Each domain score ranges from 0 to 100. For most domains, higher scores indicate better perceived health or functioning. In this study, Role Physical and Role Emotional were retained as limitation scores, for which higher scores indicate greater limitation and therefore a worse outcome. Change from baseline to post-intervention was compared across the three study groups.

    Baseline and post-intervention, after completion of the 12-session intervention period (approximately 6 weeks)

Study Arms (3)

VR-Assisted Reminiscence Therapy (RT+VR)

EXPERIMENTAL

Participants received individual reminiscence therapy supported by immersive virtual reality. The intervention comprised 12 individual sessions, delivered twice weekly and lasting approximately 35 minutes each. Immersive virtual environments were used as contextual and autobiographical cues to facilitate reminiscence. Participants remained seated during VR exposure, and virtual scenarios were managed by an external operator to minimize cognitive and operational demands.

Behavioral: Virtual Reality-Assisted Reminiscence Therapy

Traditional Reminiscence Therapy (RT)

ACTIVE COMPARATOR

Participants received individual traditional reminiscence therapy without virtual reality. The intervention was dose-matched to the RT+VR condition, with 12 individual sessions delivered twice weekly and lasting approximately 35 minutes each. Reminiscence was facilitated using conventional autobiographical cues, including photographs, objects, and guided discussion of personal memories.

Behavioral: Traditional Reminiscence Therapy

Usual Care

NO INTERVENTION

Participants continued the routine activities provided by their day-care centre and did not receive structured reminiscence therapy or virtual reality as part of the study.

Interventions

Individual reminiscence therapy supported by immersive virtual reality was delivered in 12 sessions, twice weekly, lasting approximately 35 minutes each. Participants remained seated and experienced immersive virtual environments through a Meta Quest 3 head-mounted display. The virtual environments provided contextual and autobiographical cues to facilitate the retrieval and narration of personal memories. Scenario selection and switching were managed by an external operator to reduce cognitive and operational demands on participants. Sessions were conducted by trained psychologists.

Also known as: RT+VR
VR-Assisted Reminiscence Therapy (RT+VR)

Individual traditional reminiscence therapy was delivered in 12 sessions, twice weekly, lasting approximately 35 minutes each. Trained psychologists facilitated the retrieval and narration of autobiographical memories using conventional reminiscence cues, including photographs, objects, and guided discussion of personally meaningful memories. The intervention was delivered without immersive virtual reality and was matched to the VR-assisted reminiscence therapy condition in number, frequency, and approximate duration of sessions.

Also known as: RT
Traditional Reminiscence Therapy (RT)

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Older adults attending one of the participating day-care centres.
  • Presence of mild-to-moderate cognitive impairment, as determined by the study's cognitive screening criteria.
  • Ability to participate in the study procedures and reminiscence therapy sessions.
  • Provision of written informed consent by the participant and/or, where required, by a legal representative.

You may not qualify if:

  • Severe or very severe cognitive impairment below the MMSE eligibility threshold.
  • Major visual impairment incompatible with the use of immersive virtual reality or study procedures.
  • Absence of informed consent from the participant and/or legal representative where required.
  • Clinical or functional conditions preventing safe participation in the intervention or completion of study procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centro Diurno Casetta Michelino

Padova, Padova/Veneto, 35133, Italy

Location

Centro Diurno FAI Padova

Padova, Padova/Veneto, 35141, Italy

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • DAVIDE MARIA MARCHIORO, PhD

    IUS - ISTITUTO UNIVERSITARIO SALESIANO VENEZIA-MESTRE

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessments were conducted by psychologists who were not involved in intervention delivery and were blinded to participants' group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were assigned to one of three parallel study arms: VR-assisted reminiscence therapy, traditional reminiscence therapy, or usual care.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Psychology Area and Principal Investigator

Study Record Dates

First Submitted

September 12, 2026

First Posted

September 17, 2026

Study Start

April 7, 2024

Primary Completion

July 22, 2024

Study Completion

December 21, 2024

Last Updated

September 24, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the results reported in the published article may be made available upon reasonable request, subject to applicable ethical, privacy, and data-protection requirements.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available following publication of the study results. No predetermined end date is specified.
Access Criteria
Data may be made available to qualified researchers upon reasonable request to the corresponding author. Requests should include the purpose of the proposed analysis and will be evaluated in accordance with ethical, privacy, and data-protection requirements.

Locations